Abstract
In 2009, Coxiella burnetii caused a large regional outbreak of Q fever in South Limburg, the Netherlands. Here, we announce the genome draft sequence of a human C. burnetii isolate, strain NL-Limburg, originating from this outbreak, including a brief summary of the genome’s general features.
GENOME ANNOUNCEMENT
Q fever is a zoonotic disease caused by Coxiella burnetii. Acute human infections are often asymptomatic or characterized by mild flu-like symptoms. Though rarely observed, chronic Q fever, mostly affecting patients with heart valve or vascular anomalies, may be fatal (1). Published genome sequences revealed a close relationship among C. burnetii isolates originating from various sources (2–6). This sequencing project was performed with the C. burnetii strain NL-Limburg, isolated by cell culture from a surgical specimen of an abdominal aortic aneurysm in 2011. The patient had shown late sequelae from an asymptomatic primary infection and ultimately died from multiple organ failure. This fatality could be epidemiologically linked to a single-point source Q fever outbreak on a dairy goat farm located next to Voerendaal, South Limburg, the Netherlands, in 2009 (7). This outbreak totaled 253 laboratory-confirmed human cases in the region, while the actual number of residents who incurred infection was estimated to be 9,000. Genome determination of NL-Limburg may contribute to a better understanding of the biology, evolution, and virulence of this pathotype, which showed very high attack rates both in humans and animals and was associated with the largest Q fever outbreak ever reported, comprising 4,026 human cases in the Netherlands (8).
Axenic cultivation of NL-Limburg was performed in modified acidified citrate cysteine medium (ACCM-2) for 7 days at 37°C (2.5% O2, 5% CO2) (9). Isolation of genomic DNA was conducted by incubating bacteria with proteinase K/SDS at 56°C for 18 h, followed by phenol-chloroform treatment and ethanol precipitation (10). Genome sequencing on the PacBio_RS system was performed by GATC (Konstanz, Germany). A de novo genome assembly based on 92,760 reads (N50 length, 7.022; mean length and score, 4.691 and 0.86, respectively) from one SMRT cell was developed by using the SMRT Analysis (version 2.3.0) software (Pacific Biosciences, USA), resulting in a sequence coverage of 60- to 160-fold per consensus base. The draft genome sequence contains 2,214,254 bp, allocated to five contigs (C00, 1,373,721 bp; C01, 292,414 bp; CO2, 25,635 bp; C03, 472,758 bp; C04, 49,726 bp) with an average G+C content of 42.8%. Genome comparisons using different BLAST algorithms from NCBI (11) indicate that the closest relatives of the NL-Limburg isolate are RSA_331, RSA_493, and Z3055; differences are mainly based on single nucleotide polymorphisms. Contig04 comprises the complete sequence of a 37.4-kb pQpH1-like plasmid-encoding type IV secretion effector (12). Initial genome annotation was performed with the automated NCBI Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok) and revealed 2,401 genes, 2,097 CDS, 257 pseudogenes, 43 tRNAs, three rRNAs, and one noncoding RNA. Comparable to other C. burnetii genomes, the majority of the gene products are involved in metabolism of amino acids and carbohydrates, ribosomal structure and biogenesis, cell wall and membrane biogenesis, replication, recombination, and repair. Genome finishing is in progress and will contribute to the final assessment of DNA regions linked to pathogenicity of this highly virulent strain.
Nucleotide sequence accession number.
The draft genome sequence of NL-Limburg has been deposited in GenBank under the accession number JZWL00000000.
ACKNOWLEDGMENTS
We are grateful to J. Kowall, Federal Institute for Risk Assessment, and A. Hilbert, Friedrich-Loeffler-Institut, for excellent technical assistance and to Christoph König and Ralph Vogelsang, Pacific Biosciences, for supporting genome analysis. We also thank F. Stals and M. van de Cruys, Atrium Medical Center, for procuring the tissue specimen.
This work was financially supported by the Federal Institute for Risk Assessment (BfR project no. 47-002) and the Federal Ministry of Education and Research (BMBF project no. 01KI1001A).
Footnotes
Citation Hammerl JA, Mertens K, Sprague LD, Hackert VH, Buijs J, Hoebe CJ, Henning K, Neubauer H, Al Dahouk S. 2015. First draft genome sequence of a human Coxiella burnetii isolate, originating from the largest Q fever outbreak ever reported, the Netherlands, 2007 to 2010. Genome Announc 3(3):e00445-15. doi:10.1128/genomeA.00445-15.
REFERENCES
- 1.Parker NR, Barralet JH, Bell AM. 2006. Q fever. Lancet 367:679–688. doi: 10.1016/S0140-6736(06)68266-4. [DOI] [PubMed] [Google Scholar]
- 2.Rouli L, Rolain JM, El Filali A, Robert C, Raoult D. 2012. Genome sequence of Coxiella burnetii 109, a doxycycline-resistant clinical isolate. J Bacteriol 194:6939. doi: 10.1128/JB.01856-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.D’Amato F, Rouli L, Edouard S, Tyczka J, Million M, Robert C, Nguyen TT, Raoult D. 2014. The genome of Coxiella burnetii Z3055, a clone linked to the Netherlands Q fever outbreaks, provides evidence for the role of drift in the emergence of epidemic clones. Comp Immunol Microbiol Infect Dis 37:281–288. doi: 10.1016/j.cimid.2014.08.003. [DOI] [PubMed] [Google Scholar]
- 4.Walter MC, Öhrman C, Myrtennäs K, Sjödin A, Byström M, Larsson P, Macellaro A, Forsman M, Frangoulidis D. 2014. Genome sequence of Coxiella burnetii strain Namibia. Stand Genomic Sci 9:22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Seshadri R, Samuel JE. 2013. Genome sequencing of phylogenetically and phenotypically diverse Coxiella burnetii isolates. GenBank accession no. 010117 NCBI, Bethesda, MD. [Google Scholar]
- 6.Beare PA, Unsworth N, Andoh M, Voth DE, Omsland A, Gilk SD, Williams KP, Sobral BW, Kupko JJ III, Porcella SF, Samuel JE, Heinzen RA. 2009. Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella. Infect Immun 77:642–656. doi: 10.1128/IAI.01141-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hackert VH, van der Hoek W, Dukers-Muijrers N, de Bruin A, Al Dahouk S, Neubauer H, Bruggeman CA, Hoebe CJ. 2012. Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region. Clin Infect Dis 55:1591–1599. doi: 10.1093/cid/cis734. [DOI] [PubMed] [Google Scholar]
- 8.Schneeberger PM, Wintenberger C, van der Hoek W, Stahl JP. 2014. Q fever in the Netherlands—2007–2010: what we learned from the largest outbreak ever. Med Mal Infect 44:339–353. doi: 10.1016/j.medmal.2014.02.006. [DOI] [PubMed] [Google Scholar]
- 9.Omsland A, Beare PA, Hill J, Cockrell DC, Howe D, Hansen B, Samuel JE, Heinzen RA. 2011. Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium. Appl Environ Microbiol 77:3720–3725. doi: 10.1128/AEM.02826-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sambrook J, Russel D. 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
- 11.Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S, Madden TL. 2008. NCBI BLAST: a better Web interface. Nucleic Acids Res 36:W5–W9. doi: 10.1093/nar/gkn201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Maturana P, Graham JG, Sharma UM, Voth DE. 2013. Refining the plasmid-encoded type IV secretion system substrate repertoire of Coxiella burnetii. J Bacteriol 195:3269–3276. doi: 10.1128/JB.00180-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
